Active substance
Results for the substance ixekizumab
2 results
About this active substance
Ixekizumab is a monoclonal antibody used for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. It works by blocking interleukin-17A, a cytokine involved in inflammation and the development of psoriasis.
The medication is administered as a subcutaneous injection, according to a schedule determined by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include injection site reactions, upper respiratory tract infections, nausea, or headaches. In rare cases, severe allergic reactions or serious infections may occur.
Ixekizumab is not recommended for patients with hypersensitivity to this medication or active severe infections.
The medication is administered as a subcutaneous injection, according to a schedule determined by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include injection site reactions, upper respiratory tract infections, nausea, or headaches. In rare cases, severe allergic reactions or serious infections may occur.
Ixekizumab is not recommended for patients with hypersensitivity to this medication or active severe infections.
-
-
TALTZ 80mg solution for injection in pre-filled syringe ELI LILLY ORIGINAL MEDICINE